SCHEMBL4619010

SCHEMBL4619010

NC=CCc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10352734 0.83
SCHEMBL10439395 0.82 ALDH1A1 (0.41)
SCHEMBL4657208 0.82
SCHEMBL10946107 0.81 ALDH1A1 (0.38)
Ethylene Glycol SCHEMBL6423323 0.80 ALDH1A1 (0.40)
SCHEMBL11213295 0.78
SCHEMBL5642292 0.78
SCHEMBL28914169 0.78
SCHEMBL14660110 0.78
SCHEMBL28743579 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5273984-A Bismuth complex having a carboxylic acid to form a salt of the basic antagonist excluding ranitidine GLAXO GROUP LIMITED (GB) 1993-12-28 US claimed
US-20230349922-A1 H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer UNIVERSITÉ DE STRASBOURG (FR) 2023-11-02 US disclosed
EP-4196793-A1 H2 BLOCKERS TARGETING LIVER MACROPHAGES FOR THE PREVENTION AND TREATMENT OF LIVER DISEASE AND CANCER Université de Strasbourg (FR) 2023-06-21 EP disclosed
WO-2022034121-A1 H2 BLOCKERS TARGETING LIVER MACROPHAGES FOR THE PREVENTION AND TREATMENT OF LIVER DISEASE AND CANCER UNIVERSITÉ DE STRASBOURG (FR) 2022-02-17 WO disclosed
CN-106795127-A Diamine compound, dinitro compound and other compounds and preparation method thereof and relative purposes 微麦德斯公司 2017-05-31 CN disclosed
CN-106795127-A Diamine compound, dinitro compound and other compounds and preparation method thereof and relative purposes 微麦德斯公司 2017-05-31 CN disclosed
US-20160354342-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR. SHAHID MUSLIM D (US) 2016-12-08 US disclosed
US-9457011-B2 Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor SHAHID MUSLIM D (US) 2016-10-04 US disclosed
US-20150238463-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR SHAHID MUSLIM D (US) 2015-08-27 US disclosed
US-8277782-B2 Antiinflammatory agent, metalloproteinase inhibitor, anti-oxidant and modifier of cell redox status, vitamins, inhibitor of activation of nuclear factor kappa beta THE PROCTER & GAMBLE COMPANY (US) 2012-10-02 US disclosed
EP-0001699-B1 DERIVATIVES OF FURYL COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1982-02-24 EP disclosed
US-4288443-A HISTAMINE ANTAGONISTS GLAXO GROUP LIMITED (GB) 1981-09-08 US disclosed
US-4279819-A GASTROINTESTINAL DISORDERS ALLEN & HANBURYS LTD. (GB) 1981-07-21 US disclosed
US-4279819-A GASTROINTESTINAL DISORDERS ALLEN & HANBURYS LTD. (GB) 1981-07-21 US disclosed
US-4255440-A ANTIALLERGENS, ANTIULCER AGENTS ALLEN & HANBURYS LIMITED (GB) 1981-03-10 US disclosed
US-4169855-A ANTIHISTAMINES, ANTISECRETORY AGENTS Allen & Hansbury, Limited (GB) 1979-10-02 US disclosed
US-4169855-A ANTIHISTAMINES, ANTISECRETORY AGENTS Allen & Hansbury, Limited (GB) 1979-10-02 US disclosed
EP-0001699-A2 Derivatives of furyl compounds, their preparation and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1979-05-02 EP disclosed
US-4128658-A HISTAMINE ANTAGONISTS ALLEN & HANBURYS LIMITED (GB) 1978-12-05 US disclosed
US-4128658-A HISTAMINE ANTAGONISTS ALLEN & HANBURYS LIMITED (GB) 1978-12-05 US disclosed